Lisata Therapeutics
LSTA
LSTA
29 hedge funds and large institutions have $4.49M invested in Lisata Therapeutics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $77K
Holders
29
Holding in Top 10
–
Calls
$1K
Puts
$77K
Top Buyers
| 1 | +$461K | |
| 2 | +$266K | |
| 3 | +$63K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.2K |
| 5 |
Morgan Stanley
New York
|
+$23K |
Top Sellers
| 1 | -$226K | |
| 2 | -$65.3K | |
| 3 | -$17.1K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.39K |
| 5 |
Barclays
London,
United Kingdom
|
-$3.28K |